Celularity annual stock-based compensation
2020
2021
2022
2023
2024
2025
Celularity Stock-Based Compensation Growth & History (CELU)
Celularity's stock-based compensation was $10.6M for fiscal 2025.
View full Celularity company overviewCelularity annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $10.6M | −$927,000 | −8.01% |
| 2024 | 2024-12-31 | $11.6M | $11.6M | — |
| 2023 | 2023-12-31 | $0 | −$15.9M | — |
| 2022 | 2022-12-31 | $15.9M | −$24.2M | −60.37% |
| 2021 | 2021-12-31 | $40.0M | $35.6M | +815.35% |
| 2020 | 2020-12-31 | $4.4M | — | — |
Celularity quarterly stock-based compensation
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $7.4M | $4.5M | +152.50% |
| Q3 2025 | 2025-09-30 | $471,000 | −$2.2M | −82.37% |
| Q2 2025 | 2025-06-30 | $108,000 | −$2.9M | −96.39% |
| Q1 2025 | 2025-03-31 | $2.6M | −$329,000 | −11.09% |
| Q4 2024 | 2024-12-31 | $2.9M | — | — |
| Q3 2024 | 2024-09-30 | $2.7M | −$926,000 | −25.74% |
| Q2 2024 | 2024-06-30 | $3.0M | −$866,000 | −22.46% |
| Q1 2024 | 2024-03-31 | $3.0M | −$1.0M | −25.63% |
| Q3 2023 | 2023-09-30 | $3.6M | −$921,000 | −20.38% |
| Q2 2023 | 2023-06-30 | $3.9M | −$673,000 | −14.86% |
| Q1 2023 | 2023-03-31 | $4.0M | $1.6M | +64.66% |
| Q4 2022 | 2022-12-31 | $4.4M | −$13.7M | −75.76% |
| Q3 2022 | 2022-09-30 | $4.5M | −$2.7M | −37.11% |
| Q2 2022 | 2022-06-30 | $4.5M | −$9.2M | −67.00% |
| Q1 2022 | 2022-03-31 | $2.4M | $1.4M | +140.04% |
| Q4 2021 | 2021-12-31 | $18.1M | — | — |
| Q3 2021 | 2021-09-30 | $7.2M | $6.1M | +563.53% |
| Q2 2021 | 2021-06-30 | $13.7M | — | — |
| Q1 2021 | 2021-03-31 | $1.0M | — | — |
| Q3 2020 | 2020-09-30 | $1.1M | — | — |
Celularity stock-based compensation trends
Over the last five fiscal years, Celularity's stock-based compensation increased from $4.4M to $10.6M, a change of $6.3M. The latest reported quarter, Q4 2025, shows $7.4M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Celularity source filings ↗